Invention Grant
- Patent Title: Dihydropyrazole azepine compound serving as Akt inhibitor
-
Application No.: US16309648Application Date: 2017-06-13
-
Publication No.: US10654868B2Publication Date: 2020-05-19
- Inventor: Lun Lu , Zhibo Zhang , Gang Li , Lihong Hu , Charles Z. Ding , Shuhui Chen
- Applicant: HARBIN ZHENBAO PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Heilongjiang
- Assignee: HARBIN ZHENBAO PHARMACEUTICAL CO., LTD.
- Current Assignee: HARBIN ZHENBAO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Heilongjiang
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@66038f0e com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@65a24aa3
- International Application: PCT/CN2017/088030 WO 20170613
- International Announcement: WO2017/215588 WO 20171221
- Main IPC: C07D495/14
- IPC: C07D495/14 ; C07D498/14 ; C07D491/147 ; A61P19/02 ; A61P3/10 ; A61P35/00 ; C07D487/14 ; A61K31/553 ; A61K31/551 ; A61P29/00 ; A61K31/55
Abstract:
Provided is a dihydropyrazole azepine compound serving as an Akt inhibitor; specifically disclosed is a compound as represented by formula (I) or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190233434A1 DIHYDROPYRAZOLE AZEPINE COMPOUND SERVING AS AKT INHIBITOR Public/Granted day:2019-08-01
Information query
